Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Linneberg

Showing results (371-380 of 500) with videos related to

Pageof 50
Sort By:
Addiction (Abingdon, England)|June 9, 2021
Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population-based studyAugusto Di Castelnuovo, Simona Costanzo, Marialaura Bonaccio, et al.
BMJ Open|December 16, 2025
Association between carotid-femoral pulse wave velocity and cardiovascular disease in individuals with moderate blood pressure: a systematic review and individual participant meta-analysisHolly Pavey, Angela Wood, Carmel M Mceniery, et al.
Journal of the American Heart Association|March 24, 2022
Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial FibrillationStephan Camen, Dora Csengeri, Bastiaan Geelhoed, et al.
Hypertension (Dallas, Tex. : 1979)|April 11, 2020
Does Estimated Pulse Wave Velocity Add Prognostic Information?: MORGAM Prospective Cohort ProjectJulie K K Vishram-Nielsen, Stephane Laurent, Peter M Nilsson, et al.
Journal of the American College of Cardiology|July 3, 2024
Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart DiseaseNatalie Arnold, Christopher Blaum, Alina Goßling, et al.
European Journal of Preventive Cardiology|April 20, 2023
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitusPaul M Haller, Alina Goßling, Christina Magnussen, et al.
Preventive Medicine Reports|February 10, 2022
Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort projectVictoria Rosberg, Julie Kk Vishram-Nielsen, Anna M Dyrvig Kristensen, et al.
European Heart Journal|January 19, 2024
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE projectNatalie Arnold, Christopher Blaum, Alina Goßling, et al.
Diabetologia|December 15, 2018
A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuriaTarunveer S Ahluwalia, Christina-Alexandra Schulz, Johannes Waage, et al.
European Journal of Clinical Investigation|January 5, 2023
Risk prediction of atrial fibrillation and its complications in the community using hs troponin IChristin S Börschel, Bastiaan Geelhoed, Teemu Niiranen, et al.
Pageof 50

Showing results (371-380 of 500) with videos related to

Sort By:
Pageof 50
Addiction (Abingdon, England)|June 9, 2021
Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population-based studyAugusto Di Castelnuovo, Simona Costanzo, Marialaura Bonaccio, et al.
BMJ Open|December 16, 2025
Association between carotid-femoral pulse wave velocity and cardiovascular disease in individuals with moderate blood pressure: a systematic review and individual participant meta-analysisHolly Pavey, Angela Wood, Carmel M Mceniery, et al.
Journal of the American Heart Association|March 24, 2022
Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial FibrillationStephan Camen, Dora Csengeri, Bastiaan Geelhoed, et al.
Hypertension (Dallas, Tex. : 1979)|April 11, 2020
Does Estimated Pulse Wave Velocity Add Prognostic Information?: MORGAM Prospective Cohort ProjectJulie K K Vishram-Nielsen, Stephane Laurent, Peter M Nilsson, et al.
Journal of the American College of Cardiology|July 3, 2024
Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart DiseaseNatalie Arnold, Christopher Blaum, Alina Goßling, et al.
European Journal of Preventive Cardiology|April 20, 2023
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitusPaul M Haller, Alina Goßling, Christina Magnussen, et al.
Preventive Medicine Reports|February 10, 2022
Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort projectVictoria Rosberg, Julie Kk Vishram-Nielsen, Anna M Dyrvig Kristensen, et al.
European Heart Journal|January 19, 2024
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE projectNatalie Arnold, Christopher Blaum, Alina Goßling, et al.
Diabetologia|December 15, 2018
A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuriaTarunveer S Ahluwalia, Christina-Alexandra Schulz, Johannes Waage, et al.
European Journal of Clinical Investigation|January 5, 2023
Risk prediction of atrial fibrillation and its complications in the community using hs troponin IChristin S Börschel, Bastiaan Geelhoed, Teemu Niiranen, et al.
Pageof 50